Search company, investor...

Predict your next investment

Private Equity
consonancecapital.com

Investments

14

Portfolio Exits

5

Funds

3

About Consonance Capital

Consonance Capital is a healthcare investment firm that invests broadly across the healthcare landscape. Private investments, which include growth equity, leveraged buyouts, and recapitalizations, are made under the direction of Consonance Capital Partners, a private equity manager led by Mitchell Blutt, MD, Benjamin Edmands, Stephen McKenna, and Nancy-Ann DeParle. Public investments are made under the direction of Consonance Capital Management, a long/short public equity manager. Consonance Capital was established in 2005 and is located in New York City.

Headquarters Location

1370 Avenue of the Americas 33rd Floor

New York, New York, 10019,

United States

212-660-8060

Want to inform investors similar to Consonance Capital about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Latest Consonance Capital News

VSS appoints Kim as principal and Parepally as VP

Jul 28, 2022

11h agoPrivate EquitypehubViews: 6 Prior to joining the firm, Kim led cross-functional teams at Optum while Parepally was previously an associate at Consonance Capital. Not a member yet? Free Membership for Qualified Investors and Industry Participants Easily Customize Content to Match Your Investment Preferences Breaking News 24/7/365 Alternative Investment Listings & LeaderBoards Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets,Presentations, Investment Mandates, Video PitchBooks & More! Company Directory AUM Accelerator Program (designed for investment managers) Over 450K+ Industry Headlines, Posts and Updates ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY.CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN.PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS.THIS IS NOT A SOLICITATION FOR INVESTMENT.THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY.IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES.ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM.PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT. ALPHAMAVEN

Consonance Capital Investments

14 Investments

Consonance Capital has made 14 investments. Their latest investment was in Calviri as part of their Unattributed - III on November 11, 2021.

CBI Logo

Consonance Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

11/9/2021

Unattributed - III

Calviri

$5.15M

Yes

1

8/26/2021

Seed VC

Sugar

$2.5M

Yes

12

5/5/2021

Seed VC

Lami

$1.8M

Yes

16

3/30/2021

Seed VC - II

Subscribe to see more

$99M

Subscribe to see more

10

5/26/2020

PIPE

Subscribe to see more

$99M

Subscribe to see more

10

Date

11/9/2021

8/26/2021

5/5/2021

3/30/2021

5/26/2020

Round

Unattributed - III

Seed VC

Seed VC

Seed VC - II

PIPE

Company

Calviri

Sugar

Lami

Subscribe to see more

Subscribe to see more

Amount

$5.15M

$2.5M

$1.8M

$99M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

12

16

10

10

Consonance Capital Portfolio Exits

5 Portfolio Exits

Consonance Capital has 5 portfolio exits. Their latest portfolio exit was Kepro on November 09, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

11/9/2022

Merger

$99M

7

2/14/2020

Take Private

Subscribe to see more

$99M

Subscribe to see more

10

12/16/2019

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

5/8/2014

IPO

Subscribe to see more

$99M

Subscribe to see more

10

6/12/2006

IPO

Subscribe to see more

$99M

Subscribe to see more

0

Date

11/9/2022

2/14/2020

12/16/2019

5/8/2014

6/12/2006

Exit

Merger

Take Private

Acquired

IPO

IPO

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

7

10

10

10

0

Consonance Capital Acquisitions

5 Acquisitions

Consonance Capital acquired 5 companies. Their latest acquisition was APS Healthcare on May 07, 2015.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

5/7/2015

Series C

$99M

$14.15M

Acq - Fin - II

1

8/18/2014

Subscribe to see more

$99M

Subscribe to see more

10

8/18/2014

Subscribe to see more

$99M

Subscribe to see more

10

5/29/2014

Subscribe to see more

$99M

Subscribe to see more

10

3/18/2014

Private Equity

Subscribe to see more

$99M

Subscribe to see more

10

Date

5/7/2015

8/18/2014

8/18/2014

5/29/2014

3/18/2014

Investment Stage

Series C

Private Equity

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Total Funding

$14.15M

Note

Acq - Fin - II

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

10

10

10

10

Consonance Capital Fund History

3 Fund Histories

Consonance Capital has 3 funds, including Consonance Private Equity II.

Closing Date

Fund

Fund Type

Status

Amount

Sources

4/28/2020

Consonance Private Equity II

Industry Focused

Open

$856M

3

4/24/2020

Consonance Private Equity PV II

$99M

10

7/21/2014

Consonance Capital Healthcare Fund

Subscribe to see more

Subscribe to see more

$99M

10

Closing Date

4/28/2020

4/24/2020

7/21/2014

Fund

Consonance Private Equity II

Consonance Private Equity PV II

Consonance Capital Healthcare Fund

Fund Type

Industry Focused

Subscribe to see more

Status

Open

Subscribe to see more

Amount

$856M

$99M

$99M

Sources

3

10

10

Consonance Capital Team

3 Team Members

Consonance Capital has 3 team members, including current Founder, Chief Executive Officer, Mitchell Blutt.

Name

Work History

Title

Status

Mitchell Blutt

Founder, Chief Executive Officer

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Mitchell Blutt

Subscribe to see more

Subscribe to see more

Work History

Title

Founder, Chief Executive Officer

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.